10 years with dpp-4 inhibition–role of sitagliptin in different t2dm population - prof lobna eltouny
Published 3 years ago • 139 plays • Length 17:02Download video MP4
Download video MP3
Similar videos
-
4:38
how does sitagliptin work? dpp-4 inhibitors and glp-1 mimetics
-
11:43
sitagliptin for type 2 diabetes mellitus | dpp 4 inhibitor | mechanism, precautions & side effects
-
4:22
dpp4 -inhibitors - sitaglipin, alogliptin, linagliptin, vildagliptin
-
51:19
continuing role of dpp-4 inhibitor in diabetes management
-
1:14:16
2nd session: dpp 4 inhibitors. new class of non insulin anti diabetic agents
-
3:18
diabetes medications - dpp-4 inhibitors - sitagliptin (januvia)
-
1:54
overbasalization - combination basal insulin glp-1ra therapy
-
0:53
did you know that in 10 years, 50% of the population might be using glp-1 receptor agonist dr*gs?
-
3:04
dipeptidyl peptidase-4 inhibitors is associated with risk of inflammatory bowel disease in patients
-
3:21
diabetes medications - dpp 4 inhibitors - saxagliptin (onglyza)
-
1:14
case scenario 2 - combination basal insulin glp-1ra therapy
-
10:11
oral hypoglycemic drugs (dpp-4 inhibitors)@doctorug4801 @doctorsquish
-
1:01
dpp4 inhibitors - overview
-
8:50
updates from the hope-b trial: etranacogene dezaparvovec in adults with hemophilia b
-
4:00
diabetes medications - dpp 4 inhibitors - linagliptin (trajenta)
-
4:42
“insulin, gliptins and diabetes management” by dr. raghu satyanarayan
-
1:00
dpp4 inhibitors overview
-
1:14
dpp4 inhibitors is a class of medications that are commonly used to treat diabetes